隔物灸联合抗菌药物治疗盆腔炎的临床效果观察盖晓芳

往期阅览 · All Issues-> 2025年 · 2025

中外临床医学，2025年，第1卷，第2期，第26-28页，pISSN 3080-7611、eISSN 3080-762X

发布者：Quest Press

发布日期：2025/10/19

doi 10.12479/questpress-zwlcyx.20250207

Open Access

浏览494次

Download PDF | 全文下载

隔物灸联合抗菌药物治疗盆腔炎的临床效果观察

盖晓芳

东营市第五人民医院，山东东营，257500

摘要：目的探究常规治疗方法（抗菌治疗）联合隔物灸对盆腔炎的治疗效果。方法纳入2024.08-2024.12 治疗的80 例盆腔炎患者为对象（由抽签分为2 组，40 例/ 组），抗菌治疗、抗菌+ 隔物灸分别引入对照组、观察组，对比差异。结果比对比组，试验组疗效更高、炎症指标（CRP、IL-6）更低、中医症候积分更高（P<0.05）。结论隔物灸联合抗菌药物治疗可以显著降低患者体内炎症水平，也可显著减轻盆腔炎中医症状，可获取较高的治疗疗效。

关健词：隔物灸；抗菌药物治疗；盆腔炎；炎症指标；疗效

Observation of the clinical effect of moxibus tion combined with antibiotics in the treatment of pelvic inflammatory disease

Xiaofang Gai

Dongying Fifth People’s Hospital, Dongying, Shandong 257500 , China

Abstract:Objective To explore the therapeutic effect of conventional treatment methods (antibacterial therapy) combined withmoxibustion on pelvic inflammatory disease. Methods 80 patients with pelvic inflammatory disease treated from August 2024to December 2024 were included as the subjects (divided into 2 groups by drawing lots, 40 cases/group). Antibacterial treatmentand antibacterial+moxibustion were introduced into the control group and observation group, respectively, and the differenceswere compared. Result Compared with the control group, the experimental group had higher efficacy, lower inflammatory indicators(CRP, IL-6), and higher traditional Chinese medicine symptom scores (P<0.05). Conclusion The combination of moxibustionwith antibiotics can significantly reduce the level of inflammation in patients’ bodies and alleviate traditional Chinesemedicine symptoms of pelvic inflammatory disease, achieving a high therapeutic effect.

Keywords : separated moxibustion; Antibacterial drug therapy; pelvic infection; Inflammatory markers; efficacy

论文收录证明 / 文献检索报告

Document Retrieval Certificate / Proof of Publication Indexing

作者贡献声明 / 贡献确认书

Author Contribution Statement / Certificate of Authorship Contribution

同行评审报告 / 评审意见

Peer Review Report / Peer Review Comments

利益冲突

Conflict of Interest

作者声明不存在任何利益冲突。

The author declares no conflict of interest.

本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问： https://creativecommons.org/licenses/by/4.0/。

This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.